4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-25-013993
CHIEF SCIENTIFIC OFFICER sold 5,000 shares at $16.31 ($81,534)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lyssikatos Joseph P · CHIEF SCIENTIFIC OFFICER
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-05-19 | Sale : show line 1 in the form 10b5-1 | −5,000 | $16.31 | $81,534 | 985,188 | I |
| Open-market sales · 5,000 sh · avg $16.31 · $81,534 | ||||||
Loading xslF345X05/form4-05212025_100540.xml…